IP Verse

Anti-Dll3 Antibody - EP3342786

The patent EP3342786 was granted to Chugai Seiyaku Kabushiki Kaisha on Jun 23, 2021. The application was originally filed on Jan 28, 2011 under application number EP18156974A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3342786

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP18156974A
Filing Date
Jan 28, 2011
Status
Granted And Under Opposition
May 21, 2021
Grant Date
Jun 23, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIMMar 22, 2022HOFFMANN EITLE -
GUDERMar 16, 2022UEXKULL & STOLBERGADMISSIBLE

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0239400
DESCRIPTIONEP0404097
DESCRIPTIONJPS6459878
DESCRIPTIONWO0061739
DESCRIPTIONWO02079255
DESCRIPTIONWO0231140
DESCRIPTIONWO03104453
DESCRIPTIONWO2005017155
DESCRIPTIONWO2008093688
DESCRIPTIONWO9203918
DESCRIPTIONWO9311161
DESCRIPTIONWO9312227
DESCRIPTIONWO9402602
DESCRIPTIONWO9411523
DESCRIPTIONWO9425585
DESCRIPTIONWO9602576
DESCRIPTIONWO9954342
EXAMINATIONEP2817338
EXAMINATIONWO2004030615
EXAMINATIONWO2004053102
EXAMINATIONWO2007080597
EXAMINATIONWO2013126746
EXAMINATIONWO2015127407
OPPOSITIONUS2003180784
OPPOSITIONUS2005137130
OPPOSITIONUS2008220495
OPPOSITIONWO03025138
OPPOSITIONWO2007080597
OPPOSITIONWO2009124931
OPPOSITIONWO9845434
SEARCHWO2007111733
SEARCHWO2009124931

Non-Patent Literature (NPL) Citations (104) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- Acta Oncol, (19930000), vol. 32, pages 825 - 830-
DESCRIPTION- BELYAVSKY, A. et al., Nucleic Acids Res., (19890000), vol. 17, pages 2919 - 2932-
DESCRIPTION- BETTER et al., Science, (19880000), vol. 240, pages 1041 - 1043-
DESCRIPTION- BETTER, M.; HORWITZ, A. H., Methods in Enzymology, (19890000), vol. 178, pages 476 - 496-
DESCRIPTION- BIRD, R. E. et al., TIBTECH, (19910000), vol. 9, pages 132 - 137-
DESCRIPTION- BOLOGNESI A. et al., Clin. exp. Immunol., (19920000), vol. 89, pages 341 - 346-
DESCRIPTION- BULMAN, M. P. et al., Nat Genet, (20000000), vol. 24, pages 438 - 441-
DESCRIPTION- CASELLAS P. et al., Eur. J. Biochem., (19880000), vol. 176, pages 581 - 588-
DESCRIPTION- Cellular Molecular Immunology, (20060000), vol. 3, pages 439 - 443-
DESCRIPTION- CHIRGWIN, J. M. et al., Biochemistry, (19790000), vol. 18, pages 5294 - 5299-
DESCRIPTION- CHOMCZYNSKI, P. et al., Anal. Biochem., (19870000), vol. 162, pages 156 - 159-
DESCRIPTION- CO, M. S. et al., J. Immunol., (19940000), vol. 152, pages 2968 - 2976-
DESCRIPTION- CUMBER A. J. et al., J. Immunol. Methods, (19900000), vol. 135, pages 15 - 24-
DESCRIPTION- Current Topics in Microbiology and Immunology, (19780000), vol. 81, pages 1 - 7-
DESCRIPTION- DALBADIE-MCFARLAND, G. et al., Proc. Natl. Acad. Sci. USA, (19820000), vol. 79, pages 6409 - 6413-
DESCRIPTION- DE ST. GROTH, S. F. et al., J. Immunol. Methods, (19800000), vol. 35, pages 1 - 21-
DESCRIPTION- EBERT, K. M. et al., Bio/Technology, (19940000), vol. 12, pages 699 - 702-
DESCRIPTION- FASEBJ, (19920000), vol. 6, pages 2422 - 2427-
DESCRIPTION- FROHMAN, M. A. et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 8998 - 9002-
DESCRIPTION- FULTON R. J. et al., J. Biol. Chem., (19860000), vol. 261, pages 5314 - 5319-
DESCRIPTION- GALFRE, G. et al., Nature, (19790000), vol. 277, pages 131 - 133-
DESCRIPTION- GEFFERS, I. et al., J Cell Biol, (20070000), vol. 178, pages 465 - 476-
DESCRIPTION- GHEEITE V. et al., J. Immunol. Methods, (19910000), vol. 142, pages 223 - 230-
DESCRIPTION- HASHIMOTO-GOTOH, T. et al., Gene, (19950000), vol. 152, pages 271 - 275-
DESCRIPTION- HOLLIGER P et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- HUDSON et al., J Immunol. Methods, (19990000), vol. 231, pages 177 - 189-
DESCRIPTION- HUSTON, J. S. et al., Proc. Natl. Acad. Sci. U.S.A, (19880000), vol. 85, pages 5879 - 5883-
DESCRIPTION- J. Immunol., (19790000), vol. 123, pages 1548 - 1550-
DESCRIPTION- J. Mol. Biol., (19910000), vol. 222, pages 581 - 597-
DESCRIPTION- KENYA SHITARA, YAKUGAKU ZASSHI, (20090000), vol. 129, pages 3 - 9-
DESCRIPTION- KOHLER. G.; MILSTEIN, C., Eur. J. Immunol., (19760000), vol. 6, pages 511 - 519-
DESCRIPTION- KOHLER. G.; MILSTEIN, C., Methods Enzymol., (19810000), vol. 73, pages 3 - 46-
DESCRIPTION- KRAMER, W. et al., Nucleic Acids Res., (19840000), vol. 12, pages 9441 - 9456-
DESCRIPTION- KRAMER W; FRITZ HJ, Methods. Enzymol., (19870000), vol. 154, pages 350 - 367-
DESCRIPTION- KUNKEL, Methods Enzymol., (19880000), vol. 85, pages 2763 - 2766-
DESCRIPTION- KUNKEL, TA, Proc Natl Acad Sci USA., (19850000), vol. 82, pages 488 - 492-
DESCRIPTION- LADI, E. et al., J Cell Biol, (20050000), vol. 170, pages 983 - 992-
DESCRIPTION- LAMOYI, E., Methods in Enzymology, (19860000), vol. 121, pages 652 - 663-
DESCRIPTION- LANGONE J. J. et al., Methods in Enzymology, (19830000), vol. 93, pages 307 - 308-
DESCRIPTION- LEI, S. P. et al., J. Bacteriol., (19870000), vol. 169, page 4379-
DESCRIPTION- MARGULIES. D. H. et al., Cell, (19760000), vol. 8, pages 405 - 415-
DESCRIPTION- MARK, D. F. et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 5662 - 5666-
DESCRIPTION- MIZUSHIMA et al., Nucleic Acids Res., (19900000), vol. 18, page 5322-
DESCRIPTION- MULLEDNDORE, M. E., Clin Cancer Res, (20090000), vol. 15, pages 2291 - 2301-
DESCRIPTION- MULLIGAN et al., Nature, (19790000), vol. 277, page 108-
DESCRIPTION- Nature Medicine, (19960000), vol. 2, pages 350 - 353-
DESCRIPTION- PHILLIPS, H. S., Cancer Cell, (20060000), vol. 9, pages 157 - 173-
DESCRIPTION- PLUECKTHUN, A.; SKERRA, A., Methods in Enzymology, (19890000), vol. 178, pages 497 - 515-
DESCRIPTION- Protein Engineering, (19960000), vol. 9, no. 3, pages 299 - 305-
DESCRIPTION- Remington's Pharmaceutical Science, Mark Publishing Company-
DESCRIPTION- ROUSSEAUX, J. et al., Methods in Enzymology, (19860000), vol. 121, pages 663 - 669-
DESCRIPTION- SAMBROOK, J. et al., Molecular Cloning, Cold Spring Harbor Lab. Press, (19890000), pages 9.47 - 9.58-
DESCRIPTION- SATO, K. et al., Cancer Res, (19930000), vol. 53, pages 851 - 856-
DESCRIPTION- SHULMAN, M. et al., Nature, (19780000), vol. 276, pages 269 - 270-
DESCRIPTION- SIVAM G. et al., Cancer Res., (19870000), vol. 47, pages 3169 - 3173-
DESCRIPTION- STIRPE F.; BARBIERI L., FEBS letter, (19860000), vol. 195, pages 1 - 8-
DESCRIPTION- THORPE P. E. et al., Cancer Res., (19870000), vol. 47, pages 5924 - 5931-
DESCRIPTION- TROWBRIDGE, I. S., J. Exp. Med., (19780000), vol. 148, pages 313 - 323-
DESCRIPTION- TURNPENNY, P. D. et al., J Med Genet, (20030000), vol. 40, pages 333 - 339-
DESCRIPTION- VANDAMME, A. M. et al., Eur. J. Biochem., (19900000), vol. 192, pages 767 - 775-
DESCRIPTION- WANG, A. et al., Science, vol. 224, pages 1431 - 1433-
DESCRIPTION- WARD et al., Nature, (19890000), vol. 341, pages 544 - 546-
DESCRIPTION- WAWRZYNCZAK E. J. et al., Br. J. Cancer, (19920000), vol. 66, pages 361 - 366-
DESCRIPTION- WAWRZYNCZAK E. J. et al., Cancer Res., (19900000), vol. 50, pages 7519 - 7562-
DESCRIPTION- WAWRZYNCZAKE. J. et al., Cancer Res., (19900000), vol. 50, pages 7519 - 7562-
DESCRIPTION- ZOLLER, MJ; SMITH, M., Methods Enzymol., (19830000), vol. 100, pages 468 - 500-
DESCRIPTION- ZOLLER, M. J.; SMITH, M., Nucleic Acids Research, (19820000), vol. 10, pages 6487 - 6500-
EXAMINATION- GREENBAUM D ET AL, "COMPARING PROTEIN ABUNDANCE AND MRNA EXPRESSION LEVELS ON A GENOMIC SCALE", GENOME BIOLOGY (ONLINE), BIOMED CENTRAL LTD, GB, (20030101), vol. 40, no. 9, ISSN 1465-6914, pages 117.01 - 117.08, XP008036618-
EXAMINATION- MAIER T ET AL, "Correlation of mRNA and protein in complex biological samples", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 583, no. 24, ISSN 0014-5793, (20091217), pages 3966 - 3973, (20091020), XP026815742-
EXAMINATION- R&D SYSTEMS, "Human DLL3 Antibody Monoclonal Mouse IgG2B Clone # 378703, Catalog Number: MAB4315", INTERNET CITATION, (20100505), page 1, URL: http://www.rndsystems.com/pdf/MAB4315.pdf, (20120518), XP002697358-
EXAMINATION- SPIRIN ALEXANDER S., "Storage of messenger RNA in eukaryotes: Envelopment with protein, translational barrier at 5' side, or conformational masking by 3' side?", NEW YORK, NY, US, vol. 38, no. 1, doi:10.1002/mrd.1080380117, ISSN 1040-452X, (19940501), pages 107 - 117, MOLECULAR REPRODUCTION AND DEVELOPMENT, URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mrd.1080380117, XP055782453
EXAMINATION- STEFAN C GRANT ET AL, "Targeting of small- cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial", EUROPEAN JOURNAL OF NUCLEAR MEDICINE, (19960201), vol. 23, no. 2, doi:10.1007/BF01731837, pages 145 - 149, XP055549261
EXAMINATION- LIVINGSTON P O ET AL, "Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy", CANCER IMMUNOLOGY, IMMUNOTHERAPY, SPRINGER, BERLIN, DE, (20051001), vol. 54, no. 10, doi:10.1007/S00262-005-0663-8, ISSN 1432-0851, pages 1018 - 1025, XP019333066
EXAMINATION- DUNWOODIE ET AL, "The role of Notch in patterning the human vertebral column", CURRENT OPINION IN GENETICS & DEVELOPMENT, CURRENT BIOLOGY LTD, XX, vol. 19, no. 4, doi:10.1016/J.GDE.2009.06.005, ISSN 0959-437X, (20090801), pages 329 - 337, (20090714), XP026499467
EXAMINATION- B D'SOUZA ET AL, "The many facets of Notch ligands", ONCOGENE, London, (20080901), vol. 27, no. 38, doi:10.1038/onc.2008.229, ISSN 0950-9232, pages 5148 - 5167, XP055549266
EXAMINATION- ENA LADI ET AL, "The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands", THE JOURNAL OF CELL BIOLOGY, US, (20050906), vol. 170, no. 6, doi:10.1083/jcb.200503113, ISSN 0021-9525, pages 983 - 992, XP055549301
EXAMINATION- INSA GEFFERS ET AL, "Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo", THE JOURNAL OF CELL BIOLOGY, US, (20070730), vol. 178, no. 3, doi:10.1083/jcb.200702009, ISSN 0021-9525, pages 465 - 476, XP055549269
EXAMINATION- RANJAN MUKUL ET AL, "Masking mRNA from translation in somatic cells.", US, vol. 7, no. 9, doi:10.1101/gad.7.9.1725, ISSN 0890-9369, (19930901), pages 1725 - 1736, GENES & DEVELOPMENT, URL: http://genesdev.cshlp.org/content/7/9/1725.full.pdf#page=1&view=FitH, XP055782454
EXAMINATION- L. R. SAUNDERS ET AL, "A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo", SCIENCE TRANSLATIONAL MEDICINE, US, (20150826), vol. 7, no. 302, doi:10.1126/scitranslmed.aac9459, ISSN 1946-6234, pages 1 - 15, XP055288294
EXAMINATION- CARTER PAUL ET AL, "IDENTIFICATION AND VALIDATION OF CELL SURFACE ANTIGENS FOR ANTIBODY TARGETING IN ONCOLOGY", ENDOCRINE RELATED CANCER, PUBLISHED FOR THE SOCIETY OF ENDOCRINOLOGY BY THE JOURNAL OF ENDOCRINOLOGY LTD, (20040101), vol. 11, no. 4, doi:10.1677/ERC.1.00766, ISSN 1351-0088, pages 659 - 687, XP009078100
OPPOSITION- Baeuerle Patrick A; Kufer Peter; Bargou Ralf, "BiTE: Teaching antibodies to engage T-cells for cancer therapy", Current opinion in molecular therapeutics, Thomson Reuters (scietific) Ltd., (20090201), vol. 11, no. 1, ISSN 2040-3445, pages 22 - 30, XP009151509-
OPPOSITION- Greenbaum Dov, Christopher Colangelo, Kenneth Williams, Mark Gerstein, "Comparing protein abundance and mRNA expression levels on a genomic scale", Genome Biology, (20030829), vol. 4, no. 117, pages 1 - 8, XP055909703-
OPPOSITION- "Printout", (20220301), URL: https://pubmed.ncbi.nlm.nih.gov/?filter=dates.1000%2F1%2F1-2010%2F1%2F28&linkname=pubmed_pubmed_citedin&from_uid=16501043-
OPPOSITION- Sun Yu, Yu Fen And Sun Bai-Wang, "Antibody-drug conjugates as targeted cancer therapeutics", Acta Pharmaceutica Sinica, (20090101), vol. 44, no. 9, pages 943 - 952, XP055549246-
OPPOSITION- Shanchun Guo; Mingli Liu; Ruben R. Gonzalez-Perez;, "Role of Notch and its oncogenic signaling crosstalk in breast cancer", BBA - REVIEWS ON CANCER., ELSEVIER SCIENCE BV, AMSTERDAM., NL, NL , (20101217), vol. 1815, no. 2, doi:10.1016/j.bbcan.2010.12.002, ISSN 0304-419X, pages 197 - 213, XP028177024
OPPOSITION- Dunwoodie, S.L., "The role of Notch in patterning the human vertebral column", CURRENT OPINION IN GENETICS & DEVELOPMENT., CURRENT BIOLOGY LTD., XX, XX , (20090801), vol. 19, no. 4, doi:10.1016/j.gde.2009.06.005, ISSN 0959-437X, pages 329 - 337, XP026499467
OPPOSITION- Dunwoodie, S.L., "The role of Notch in patterning the human vertebral column", CURRENT OPINION IN GENETICS & DEVELOPMENT, XX , (20090801), vol. 19, no. 4, doi:10.1016/j.gde.2009.06.005, ISSN 0959-437X, pages 329 - 337, XP026499467
OPPOSITION- Dsouza Brendan, Meloty-Kapella Laurence, Weinmaster Gerry, "Canonical and non-canonical Notch ligands", Current Topics in Developmental Biology, (20100101), vol. 92, doi:10.1016/S0070-2153(10)92003-6, pages 73 - 129, XP055908974
OPPOSITION- B D'souza, A Miyamoto, G Weinmaster, "The many facets of Notch ligands", Oncogene, London , (20080901), vol. 27, no. 38, doi:10.1038/onc.2008.229, ISSN 0950-9232, pages 5148 - 5167, XP055549266
OPPOSITION- D'Souza B; Miyamoto A; Weinmaster G, "The many facets of Notch ligands", Oncogene, Nature Publishing Group UK, London, London , (20080901), vol. 27, no. 38, doi:10.1038/onc.2008.229, ISSN 0950-9232, pages 5148 - 5167, XP037744432
OPPOSITION- AYYANAN et al., Proc Natl Acad Sci USA, (20060000), vol. 103, no. 10, pages 3799 - 804, XP008167483
OPPOSITION- Ena Ladi et al, "The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands", The journal of cell biology, US , (20050912), vol. 170, no. 6, doi:10.1083/jcb.200503113, ISSN 0021-9525, pages 983 - 992, XP055549301
OPPOSITION- Ena Ladi, James T. Nichols, Weihong Ge, Alison Miyamoto, Christine Yao, Liang-Tung Yang, Jim Boulter, Yi E. Sun, Chris Kintner, Gerry Weinmaster, "The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands", The journal of cell biology, The Rockefeller University Press, US, US , (20050912), vol. 170, no. 6, doi:10.1083/jcb.200503113, ISSN 0021-9525, pages 983 - 992, XP055549301
OPPOSITION- Insa Geffers, Katrin Serth, Gavin Chapman, Robert Jaekel, Karin Schuster-Gossler, Ralf Cordes, Duncan B. Sparrow, Elisabeth Kremmer, Sally L. Dunwoodie, Thomas Klein, Achim Gossler, "Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo", The journal of cell biology, The Rockefeller University Press, US, US , (20070730), vol. 178, no. 3, doi:10.1083/jcb.200702009, ISSN 0021-9525, pages 465 - 476, XP055549269
OPPOSITION- Paul J Carter, Peter D Senter, "Antibody-Drug Conjugates for Cancer Therapy", CANCER JOURNAL, JONES AND BARTLETT PUBLISHERS, US, US , (20080501), vol. 14, no. 3, doi:10.1097/PPO.0b013e318172d704, ISSN 1528-9117, pages 154 - 169, XP055549236
OPPOSITION- KONTERMANN ROLAND E, "Recombinant bispecific antibodies for cancer therapy", Acta Pharmacologica Sinica, Nature Publishing Group, GB, GB , (20050101), vol. 26, no. 1, doi:10.1111/j.1745-7254.2005.00008.x, ISSN 1671-4083, pages 1 - 9, XP002426874
OPPOSITION- Jiang T, Collins B J, Jin N, Watkins D N, Brock M V, Matsui W, Nelkin B D, Ball D W, "Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer", Cancer research, American Association for Cancer Research, US, US , (20090201), vol. 69, no. 3, doi:10.1158/0008-5472.CAN-08-2762, ISSN 0008-5472, pages 845 - 854, XP002697824
OPPOSITION- Collu Giovanna M, Brennan Keith, "Cooperation between Wnt and Notch signalling in human breast cancer", Breast Cancer Research (Online Edition), BioMed Central Ltd., United Kingdom, Netherlands, United States, United Kingdom, Netherlands, United States , (20070511), vol. 9, no. 3, doi:10.1186/bcr1671, ISSN 1465-542X, pages 105 - 105, XP055909656
OPPOSITION- STOCKWIN L H, HOLMES S, "ANTIBODIES AS THERAPEUTIC AGENTS: VIVE LA RENAISSANCE!", EXPERT OPINION ON BIOLOGICAL THERAPY, Informa Healthcare, (20031006), vol. 03, no. 07, doi:10.1517/14712598.3.7.1133, ISSN 1471-2598, pages 1133 - 1152, XP008050055
OPPOSITION- CHEN J, ET AL., "ANTIBODY-CYTOTOXIC AGENT CONJUGATES FOR CANCER THERAPY", Expert Opinion on Drug Delivery, Informa Healthcare, GB, GB , (20050101), vol. 02, no. 05, doi:10.1517/17425247.2.5.873, ISSN 1742-5247, pages 873 - 890, XP008060439
OPPOSITION- Ercan C., J. Van Diest P., Vooijs M., "Mammary Development and Breast Cancer: The Role of Stem Cells", CURRENT MOLECULAR MEDICINE, BENTHAM SCIENCE PUBLISHERS, NL, NL , (20110601), vol. 11, no. 4, doi:10.2174/156652411795678007, ISSN 1566-5240, pages 270 - 285, XP055909689
OPPOSITION- Wang Yifan, Zhou Binhua P., "Epithelial-mesenchymal transition in breast cancer progression and metastasis", Atzheng -Chinese journal of cancer, GAI KAN BIANJIBU, GUANGZHOU, CN, CN , (20110905), vol. 30, no. 9, doi:10.5732/cjc.011.10226, ISSN 1000-467X, pages 603 - 611, XP055909693
SEARCH- MILLIPORE, "Anti-Delta3, clone 1E7.2", INTERNET CITATION, (20080715), pages 1 - 3, URL: http://www.millipore.com/catalogue/item/MABT189?cid=bios-a-antr-1012-1206, (20130514), XP002697359 [X] 1-3 * the whole document * [I] 4,6-10-
SEARCH- JIANG TIANYUN ET AL, "Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer", CANCER RESEARCH, (200902), vol. 69, no. 3, ISSN 0008-5472, pages 845 - 854, XP002697824 [I] 12 * page 847, column 2, line l - page 848, column 1, paragraph 2 * * table 1 * * figure 2 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents